Found: 6
Select item for more details and to access through your institution.
Toxicity and dosimetry of.
- Published in:
- International Journal of Cancer, 2001, v. 94, n. 6, p. 873, doi. 10.1002/ijc.1540
- By:
- Publication type:
- Article
Anticancer Activity of Targeted Proapoptotic Peptides.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 1, p. 122
- By:
- Publication type:
- Article
Preclinical Comparison of <sup>111</sup>In-Labeled DTPA- or DOTA-Bombesin Analogs for Receptor-Targeted Scintigraphy and Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2002, v. 43, n. 12, p. 1650
- By:
- Publication type:
- Article
Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 8, p. 1265, doi. 10.1007/s00259-009-1098-9
- By:
- Publication type:
- Article
Optimising conditions for radiolabelling of DOTA-peptides with [sup 90] Y, [sup 111] In and [sup 177] Lu at high specific activities.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 6, p. 917, doi. 10.1007/s00259-003-1142-0
- By:
- Publication type:
- Article
The addition of DTPA to [[sup 177] Lu-DOTA[sup 0] ,Tyr[sup 3] ]octreotate prior to administration reduces rat skeleton uptake of radioactivity.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 2, p. 312, doi. 10.1007/s00259-002-1054-4
- By:
- Publication type:
- Article